Practical prevention of vaginal and rectal transmission of HIV by adapting the oral defense: Use of commercial lubricants

AIDS Research and Human Retroviruses

Volumn 17, Issue 11, 2001, Pages 997-1002

  Baron, S ^a   Poast, J ^a   Nguyen, D ^a   Cloyd, M W ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ASTROGLIDE; CD4 ANTIGEN; LUBRICATING AGENT; NON PRESCRIPTION DRUG; NONOXINOL 9; UNCLASSIFIED DRUG; VAGISIL; VIAMOR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL FREE SYSTEM; CELL SUSPENSION; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DISEASE SIMULATION; DRUG ACTIVITY; DRUG COST; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE AVAILABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LEUKOCYTE; MALE; MUCOSA INFLAMMATION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RECTUM; SALIVA; SEMINAL PLASMA; SEXUAL TRANSMISSION; VAGINA; VIRUS LOAD; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DRUGS, NON-PRESCRIPTION; FEMALE; HIV INFECTIONS; HUMANS; IRRITANTS; LEUKOCYTES, MONONUCLEAR; LUBRICATION; MALE; MUCOUS MEMBRANE; RECTUM; SALIVA; SEMEN; VAGINA;

EID: 0034821091     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201300343672     Document Type: Article

References (27)

1. Human immunodeficiency viruses in the developing world
2. The global impact of HIV infection and disease
3. Country-specific estimates and models of HIV and AIDS: Methods and limitations
4. Mechanisms of HIV/SIV mucosal transmission
5. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier
6. Cell-mediated HTLV-1 infection of a cervix-derived epithelial cell line
7. Mechanism of HIV spread from lymphocytes to epithelia
8. Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus
9. Mucosal events in the pathogenesis of human immunodeficiency virus type 1 infection
10. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1
11. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV
12. Pathogenesis of SIVmac251 after a traumatic inoculation of the rectal mucosa in rhesus monkeys
13. SIV transmission across the mucosal barrier
14. Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes
15. Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: A novel mechanism
16. Is clearance of HIV-1 viraemia at seroconversion mediated by neutralizing antibodies?
17. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
18. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
19. HIV-specific cellular and humoral immune responses in primary HIV infection
20. Early phases of HIV type 1 in fection
21. A controlled trial of nonoxynol 9 film to reduce male-to-fe male transmission of sexually transmitted diseases
22. Vaginal microbicides
23. Efficacy of nonoxynol-contraceptive sponge use in preventing heterosexual acquisition HIV in Nairobi prostitutes
24. Vaginal drug products for over-the-counter human use; Establishment of a mongraph; Advance notice of proposed rulemaking
25. Evaluation of human and simian immunodefi ciency virus plaque and neutralization assays
26. A simple method of estimating 50 percent endpoints
27. The effectiveness of condoms in reducing heterosexual transmission of HIV